Breaking news

AstraZeneca Bolsters Cancer Treatment Capabilities With $1 Billion EsoBiotec Acquisition

The renowned British pharmaceutical company, AstraZeneca, has announced a striking move by acquiring Belgium’s EsoBiotec for an impressive sum of up to $1 billion. This acquisition is expected to significantly boost AstraZeneca’s expertise in cancer treatment formulations.

This ambitious move consists of an immediate payment of $425 million with the potential to invest an additional $575 million to meet developmental and regulatory milestones. This strategic acquisition fully supports AstraZeneca’s vision of revolutionizing cancer treatment through cutting-edge cellular therapy.

EsoBiotec’s platform is renowned for its transformative approach to cellular therapy, aiming to enhance the body’s immune defenses against cancer cells. By engineering immune cells directly within the patient’s body utilizing targeted viruses, what once took weeks for treatment could now potentially be reduced to mere minutes—a groundbreaking leap in medical technology!

Following the conclusion of this deal by the second quarter of 2025, EsoBiotec will operate as a subsidiary under AstraZeneca, continuing its innovative work from Belgium. This move aligns seamlessly with AstraZeneca’s commitment to advancing healthcare and providing innovative solutions in the realm of oncology.

Furthering The Fight Against Cancer

On the same day, AstraZeneca also announced an agreement to license multiple oncology assets from Alteogen. Such strategic partnerships underscore AstraZeneca’s dedication to pioneering advances in cancer treatment.

For more insightful developments such as these, explore the latest Biobank.cy’s Nano-Innovation Sets A New Standard In Targeted Breast Cancer Treatment.

Robust Meat Market Dynamics Ensure A Fully Stocked Easter Feast

Meat supply increased ahead of Easter 2026, with prices remaining broadly stable despite higher seasonal demand, according to data from slaughterhouses and the Consumer Protection Service Price Observatory.  Market data show higher volumes of lamb and pork alongside limited price increases across key categories.

Strong Supply And Price Stability

Recent data indicate increased meat supply compared to the same period last year, supporting availability during peak demand. Higher volumes helped limit price increases across most product categories. Stable supply conditions contributed to controlled pricing despite seasonal pressure on demand.

Enhanced Competition With Greek Lamb Imports

Market supply was supported by the import of 4,000 lambs from Greece, increasing availability and competition. Additional supply contributed to price stability across lamb products. Domestic production adjusted as imports increased, with 2,105 fewer lambs processed locally on Great Tuesday compared to the previous year.

Dynamic Production Trends In Meat Processing

A total of 19,883 lambs were slaughtered over the past six days, marking a 6% increase compared to the same period last year. Pork production also increased, with 10,655 pigs processed versus 9,452 a year earlier, representing a 13% rise. Higher output across categories reflects increased supply ahead of the holiday period.

Price Adjustments In Key Meat Categories

The average price for locally sourced lamb reached €14.10 per kg, up 4.76% compared to last year. Pork prices declined, with tenderloin averaging €5.97 per kg (-4.47%) and neck cut €6.16 per kg (-1.62%). Poultry remained stable at €4.16 per kg, recording a marginal decrease of 0.05%, maintaining its position as the lowest-cost option.

Overall Cost Implications For The Festive Table

An indicative Easter table for eight people is estimated at €186.42 in 2026 for 19 basic products, compared to €179.36 in 2025, reflecting a 3.9% increase. Meat prices had a limited impact on the increase. Higher costs were driven by vegetables, with tomatoes rising by 81.73% and cucumbers by 42.24%. Prices for fresh potatoes and olive oil declined by 12% to 19%, partially offsetting overall costs.

Aretilaw firm
eCredo
Uol
The Future Forbes Realty Global Properties

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter